A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile

Prostate-specific membrane antigen (PSMA) is a promising target for the treatment of advanced prostate cancer (PC) and various solid tumors. Although PSMA-targeted radiopharmaceutical therapy (RPT) has enabled significant imaging and prostate-specific antigen (PSA) responses, accumulating clinical d...

Descripción completa

Detalles Bibliográficos
Autores principales: Boinapally, Srikanth, Ahn, Hye-Hyun, Cheng, Bei, Brummet, Mary, Nam, Hwanhee, Gabrielson, Kathleen L., Banerjee, Sangeeta R., Minn, Il, Pomper, Martin G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007718/
https://www.ncbi.nlm.nih.gov/pubmed/33782486
http://dx.doi.org/10.1038/s41598-021-86551-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007718/
https://www.ncbi.nlm.nih.gov/pubmed/33782486
http://dx.doi.org/10.1038/s41598-021-86551-1

Ejemplares similares